Nasdaq: SMMT
Summit Therapeutics insiders
The officers, directors and 10% owners of Summit Therapeutics Inc. who hold the most stock, valued at the live SMMT price.
$10.57
SMMT today +$70K (+0.67%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 5
- Their SMMT stock
- $6.83B
- Market value
- $8.45B
- Held by ranked insiders
- 80.8%
Insiders by value of SMMT holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Robert W. Duggan | Co-Chief Executive Officer | 591,972,684 | $6.26B | 74.0% | 34th |
| 2 | Yu Xia | Director | 32,057,147 | $339M | 4.01% | 627th |
| 3 | Mahkam Zanganeh | Co-Chief Executive Officer | 18,619,805 | $197M | 2.33% | 795th |
| 4 | Manmeet Soni | COO and CFO | 3,224,375 | $34.1M | 0.40% | 3414th |
| 5 | Ankur Dhingra | Chief Financial Officer | 394,485 | $4.2M | <0.1% | 6885th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Summit Therapeutics; see each profile for the filing.